Iqvia Company profile
About Iqvia Holdings Inc
IQVIA Holdings Inc. is a provider of advanced analytics, technology solutions and clinical research services to the life sciences industry. The Company’s segments include Technology & Analytics Solutions, Research & Development Solutions and Contract Sales & Medical Solutions. Technology & Analytics Solutions provides critical information, technology solutions and real-world insights and services to its life science clients. Research & Development Solutions, which primarily serves biopharmaceutical clients, is engaged in research and development and provides clinical research and clinical trial services. Contract Sales & Medical Solutions provides contract sales to both biopharmaceutical clients and the broader healthcare market.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, Iqvia Holdings Inc revenues increased 22% to $13.87B. Net income increased from $279M to $966M. Revenues reflect Research & Development Solutions segment increase of 31% to $7.56B, Technology & Analytics Solutions segment increase of 14% to $5.53B, Contract Sales & Medical Solutions segment increase of 6% to $784M.
Equity composition
Common Stock $0.01 Par, 05/13/, Shares auth. 150M., 129,606,179 issd. Insiders owns approx. 84.77%
Latest shares articles
![](https://img.capital.com/imgs/articles/384x2000x0/1350x880_-HP-_Newsquawk-light_1.png)
![Lloyds share price forecast: An attractive dividend stock?](https://img.capital.com/imgs/articles/384x2000x0/Hero-image-bank_1.png)
![Exterior of Infosys headquarters](https://img.capital.com/imgs/articles/384x2000x0/shutterstock_2035197281_0_0.jpg)
![Tesla logo atop of a Tesla Dealership illuminated at night.](https://img.capital.com/imgs/articles/384x2000x0/shutterstock_1494516293_0.jpg)